Type I Interferon-Driven Monocyte Dysregulation and MAS-associated CD8 + T cells During Macrophage Activation Syndrome

Read full text
Authors: Susan Canny, Hannah A. DeBerg, Emma Lo Kuan, Nicholas Moss, Griffin M. Gessay, Ailing Lu, Amanda Huang, Allison R. O’Rourke, Erik D. Layton, Paige L. Bouvatte, Peter J. Wittig, Cate Speake
+6 more Carmen Mikacenic, Susan Shenoi, Joyce Hui-Yuen, Daniel Campbell, Betsy Jo Barnes, Jessica A. Hamerman
Cited by: 1
References: 76

Abstract

Abstract Macrophage activation syndrome (MAS) is driven by a hyperinflammatory response characterized by aberrant activation of lymphocytes and phagocytes. While monocytes and macrophages are thought to be important in MAS pathogenesis, their role remains poorly understood. We used bulk and single-cell RNA sequencing (RNA-Seq) on sorted monocytes from children with MAS and healthy controls to identify transcriptional changes during MAS. We defined a MAS signature in classical monocytes that correlated with ferritin and was elevated in monocytes from systemic lupus erythematosus and COVID-19 patients. We also identified a subset of classical monocytes with high levels of interferon-stimulated genes (ISGs) that expanded during MAS. Surprisingly, the transcriptional signature of these cells was driven by type I IFNs, rather than IFNγ. Consistent with this finding, we detected increased levels of circulating IFNβ during MAS, suggesting that IFNβ plays an unrecognized role in driving MAS monocyte responses. We also identified a MAS-associated CD8 + T cell population with a distinctive transcriptional signature. We used cell-cell communication algorithms to predict increased immunoregulatory interactions between monocytes and T cells during MAS. Together, these results provide new evidence for a role for type I IFN during MAS and identify a unique CD8 + T cell population that may contribute to MAS pathophysiology.

Fields of Study & Subjects

Autoimmune and Inflammatory Disorders Research Vitamin C and Antioxidants Research Immune cells in cancer

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Publication date
26 May 2026
Language
EN
Document type
Preprint